Join Cameron English and Dr. Chuck Dinerstein on Episode 131 of the Science Dispatch podcast as they discuss:
Drugs & Pharmaceuticals
News and analysis on drug development, clinical evidence, regulatory approvals, pharmacology, and the science behind treatments — from small molecules to biologics.
Politicians love a health crisis that makes for scary headlines, especially when the danger is insignificant or altogether absent.
As difficult as it is to believe, we are still having a debate about thimerosal, thanks to vaccine "skeptic" Robert F. Kennedy Jr., who is the head of HHS.
It's no secret that I'm not a big fan of Tylenol.
Semaglutide, the GLP-1 better known by its brand name Ozempic, has revolutionized the fight against obesity.
Chronic pain affects more patients than cancer, cardiovascular disease (CVD) and diabetes combined.
It's no secret that I'm a supplement skeptic [1]. Thanks to a 1994 federal law, the DSHEA [2], companies, some of which are deeply unethical, are able to sell all kinds of crap.
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
